Rapid kill assessment of an N -arylated NH125 analogue against drug-resistant microorganisms

• Published in: MedChemComm 2019-05, Vol.10 (5), p.712-716
• Main Authors: Abouelhassan, Yasmeen, Zhang, Peilan, Ding, Yousong, Huigens Iii, Robert W
• Format: Article
• Language: English
• Subjects: Chemistry
• ISSN: 2040-2503; 2040-2511
• DOI: 10.1039/c8md00613j

While a number of disinfection techniques are employed in healthcare units, the eradication of drug-resistant microorganisms remains a challenge. We recently reported -arylated NH125 analogue , which demonstrated potent biofilm eradication and antibacterial activities against a panel of drug-resistant pathogens. The broad-spectrum activities observed for along with its rapid eradication of MRSA persister cells suggested that this agent, and related analogues, can serve as disinfectants for antibiotic resistant pathogens in healthcare settings. Here, we report the rapid bactericidal activities of against a panel of exponentially-growing, drug-resistant pathogens. Against MRSA, MRSE, VRE and MDR , eradicated bacterial cells after five minutes when tested at 50 μM (3- to 6-log reduction of CFU per mL). We highlighted the rapid killing activities by demonstrating that eradicates 99.99% of viable MRSA 1707 cells in one minute (50 μM, 4-log reduction of CFU per mL). In addition, rapidly eradicated fungal pathogen in kill kinetic experiments. A solution of demonstrated similar shelf stability to known disinfectant BAC-16 when tested up to 111 days after being stored. Collectively, our data highlights the potential of to be used as a disinfecting agent to prevent healthcare-associated, drug-resistant infections.